About PDZ and LIM domain protein 3
PDZ and LIM domain protein 3 (PDLIM3) is a protein
from Homo sapiens identified by UniProt accession
Q53GG5, 364 residues long.
MolForge cross-references it against 0 known binders and
199 disease associations.
Target properties
| Protein name | PDZ and LIM domain protein 3 |
| UniProt accession | Q53GG5 |
| Gene | PDLIM3 |
| Organism | Homo sapiens |
| Length | 364 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (199)
Diseases linked to this target (Open Targets).
- hypertrophic cardiomyopathy · score 0.21
- dilated cardiomyopathy · score 0.21
- type 2 diabetes mellitus · score 0.19
- Abnormality of the cardiovascular system · score 0.16
- genetic disorder · score 0.12
- serum gamma-glutamyl transferase measurement · score 0.11
- familial hypertrophic cardiomyopathy · score 0.11
- left ventricular noncompaction · score 0.06
- Arrhythmogenic right ventricular dysplasia · score 0.06
- Sensorineural deafness with dilated cardiomyopathy · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q53GG5-F1 | alphafold | PREDICTED | 66.69 | — |
Amino-acid sequence (364 residues)
MPQTVILPGP APWGFRLSGG IDFNQPLVIT RITPGSKAAA ANLCPGDVIL AIDGFGTESM THADAQDRIK AAAHQLCLKI DRGETHLWSP QVSEDGKAHP FKINLESEPQ DGNYFEHKHN IRPKPFVIPG RSSGCSTPSG IDCGSGRSTP SSVSTVSTIC PGDLKVAAKL APNIPLEMEL PGVKIVHAQF NTPMQLYSDD NIMETLQGQV STALGETPLM SEPTASVPPE SDVYRMLHDN RNEPTQPRQS GSFRVLQGMV DDGSDDRPAG TRSVRAPVTK VHGGSGGAQR MPLCDKCGSG IVGAVVKARD KYRHPECFVC ADCNLNLKQK GYFFIEGELY CETHARARTK PPEGYDTVTL YPKA
Explore PDZ and LIM domain protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets